A carregar...
Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects
BACKGROUND: Lixisenatide is a once‐daily, prandial, short‐acting glucagon‐like peptide‐1 receptor agonist. Its main antidiabetic effect is to delay gastric emptying to control postprandial plasma glucose excursions. The dose–response relationship of the integrated insulinotropic and gastrostatic res...
Na minha lista:
| Publicado no: | Diabetes Metab Res Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744661/ https://ncbi.nlm.nih.gov/pubmed/25773712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dmrr.2647 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|